BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16424062)

  • 1. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.
    Cebrian A; Pharoah PD; Ahmed S; Smith PL; Luccarini C; Luben R; Redman K; Munday H; Easton DF; Dunning AM; Ponder BA
    Cancer Res; 2006 Jan; 66(2):1225-33. PubMed ID: 16424062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
    Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in epigenetic genes and breast cancer risk.
    Cebrian A; Pharoah PD; Ahmed S; Ropero S; Fraga MF; Smith PL; Conroy D; Luben R; Perkins B; Easton DF; Dunning AM; Esteller M; Ponder BA
    Carcinogenesis; 2006 Aug; 27(8):1661-9. PubMed ID: 16501248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.
    Chen P; Liang J; Wang Z; Zhou X; Chen L; Li M; Xie D; Hu Z; Shen H; Wang H
    Clin Cancer Res; 2008 Sep; 14(18):5931-7. PubMed ID: 18794107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNPs in ultraconserved elements and familial breast cancer risk.
    Yang R; Frank B; Hemminki K; Bartram CR; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Arnold N; Weber BH; Niederacher D; Meindl A; Burwinkel B
    Carcinogenesis; 2008 Feb; 29(2):351-5. PubMed ID: 18174240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
    Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
    J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.
    Zhang Y; Newcomb PA; Egan KM; Titus-Ernstoff L; Chanock S; Welch R; Brinton LA; Lissowska J; Bardin-Mikolajczak A; Peplonska B; Szeszenia-Dabrowska N; Zatonski W; Garcia-Closas M
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):353-8. PubMed ID: 16492928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
    Milne RL; Ribas G; González-Neira A; Fagerholm R; Salas A; González E; Dopazo J; Nevanlinna H; Robledo M; Benítez J
    Cancer Res; 2006 Oct; 66(19):9420-7. PubMed ID: 17018596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between genes involved in the antioxidant defence system and breast cancer risk.
    Oestergaard MZ; Tyrer J; Cebrian A; Shah M; Dunning AM; Ponder BA; Easton DF; Pharoah PD
    Br J Cancer; 2006 Aug; 95(4):525-31. PubMed ID: 16868544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
    Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA
    Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
    Long JR; Egan KM; Dunning L; Shu XO; Cai Q; Cai H; Dai Q; Holtzman J; Gao YT; Zheng W
    Pharmacogenet Genomics; 2006 Apr; 16(4):237-43. PubMed ID: 16538170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial genetic background modifies breast cancer risk.
    Bai RK; Leal SM; Covarrubias D; Liu A; Wong LJ
    Cancer Res; 2007 May; 67(10):4687-94. PubMed ID: 17510395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer.
    Kotsopoulos J; Zhang WW; Zhang S; McCready D; Trudeau M; Zhang P; Sun P; Narod SA
    Breast Cancer Res Treat; 2008 Dec; 112(3):585-93. PubMed ID: 18204969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
    Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A
    Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
    Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K
    Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in selenoprotein genes increase risk of colorectal cancer.
    Méplan C; Hughes DJ; Pardini B; Naccarati A; Soucek P; Vodickova L; Hlavatá I; Vrána D; Vodicka P; Hesketh JE
    Carcinogenesis; 2010 Jun; 31(6):1074-9. PubMed ID: 20378690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor variants and breast cancer risk in the Polish population.
    Gapska P; Scott RJ; Serrano-Fernandez P; Huzarski T; Byrski T; Kładny J; Gronwald J; Górski B; Cybulski C; Lubinski J; Debniak T
    Breast Cancer Res Treat; 2009 Jun; 115(3):629-33. PubMed ID: 18587672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.